A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 532
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : sCT
Long Form : salmon calcitonin
No. Year Title Co-occurring Abbreviation
2020 A Novel Photoreactive Excipient to Probe Peptide-Matrix Interactions in Lyophilized Solids. pGlcN, pLeu
2020 A thermo-sensitive injectable hydroxypropyl chitin hydrogel for sustained salmon calcitonin release with enhanced osteogenesis and hypocalcemic effects. HA, HPCH
2020 Bone targeted delivery of salmon calcitonin hydroxyapatite nanoparticles for sublingual osteoporosis therapy (SLOT). HAP-NPs, SLOT
2020 Design and Characterizations of Inhalable Poly(lactic-co-glycolic acid) Microspheres Prepared by the Fine Droplet Drying Process for a Sustained Effect of Salmon Calcitonin. FDD
2020 Effects of a selective long-acting amylin receptor agonist on alcohol consumption, food intake and body weight in male and female rats. AMYRs, CTR
2020 Effects of sub-chronic amylin receptor activation on alcohol-induced locomotor stimulation and monoamine levels in mice. CTR, LDTg, NAc, RAMPs, VTA
2020 Flash Fabrication of Orally Targeted Nanocomplexes for Improved Transport of Salmon Calcitonin across the Intestine. DS, FNC, GC-T, GI
2020 Investigation of salmon calcitonin in regulating fibrosis-related molecule production and cell-substrate adhesion in frozen shoulder synovial/capsular fibroblasts. CTRs, IHC, IL-1alpha, mRNA, PKA, PKC, SCFs, TGF-beta1
2020 Protection of Protein Drugs by Self-Emulsified Nanoemulsion Against Proteolysis. ---
10  2020 RAMP1 and RAMP3 Differentially Control Amylin's Effects on Food Intake, Glucose and Energy Balance in Male and Female Mice. AP, CTR, IMI, RAMPs, RER
11  2020 Salmon calcitonin distributes into the arcuate nucleus to a subset of NPY neurons in mice. AMY, AP, ARC, CTR, OVLT
12  2020 Thermosensitive Hydrogel Based on Poly(2-Ethyl-2-Oxazoline)-Poly(D,L-Lactide)-Poly(2-Ethyl-2-Oxazoline) for Sustained Salmon Calcitonin Delivery. PPP, SEM
13  2020 Viral depletion of calcitonin receptors in the area postrema: A proof-of-concept study. AAV, AP, CTR, GFP, NTS, RAMP
14  2019 Activation of amylin receptors attenuates alcohol-mediated behaviours in rodents. ---
15  2019 Additive and nonadditive effects of salmon calcitonin and omega-3 fatty acids on antioxidant, hematological and bone and cartilage markers in experimental diabetic-osteoarthritic rats. ---
16  2019 An amylin analogue attenuates alcohol-related behaviours in various animal models of alcohol use disorder. NAc
17  2019 Calcitonin native prefibrillar oligomers but not monomers induce membrane damage that triggers NMDA-mediated Ca2+-influx, LTP impairment and neurotoxicity. PFOs
18  2019 Combined Amylin/GLP-1 pharmacotherapy to promote and sustain long-lasting weight loss. DIO, DVC, GLP-1
19  2019 Controlled Delivery of Salmon Calcitonin Using Thermosensitive Triblock Copolymer Depot for Treatment of Osteoporosis. mPEG, PLGA
20  2019 Development of a polysaccharide based multi-unit nanofiber mat for colon-targeted sustained release of salmon calcitonin. SCF
21  2019 Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles. CS, FITC-sCT, NPs, PR
22  2019 Hexapeptide-conjugated calcitonin for targeted therapy of osteoporosis. CTRs, HA
23  2019 Inhibiting Human Calcitonin Fibril Formation with Its Most Relevant Aggregation-Resistant Analog. hCT
24  2019 Salmon calcitonin exerts better preventive effects than celecoxib on lumbar facet joint degeneration and long-term tactile allodynia in rats. CLX, COMP, FJ, micro-CT, OA
25  2019 The Interaction between Amyloid Prefibrillar Oligomers of Salmon Calcitonin and a Lipid-Raft Model: Molecular Mechanisms Leading to Membrane Damage, Ca2+-Influx and Neurotoxicity. ---
26  2018 Calcitonin and Omega-3 Fatty Acids Exhibit Antagonistic and Non-Additive Effects in Experimental Diabetes. ---
27  2018 Inhibition of the fibrillation of highly amyloidogenic human calcitonin by cucurbit[7]uril with improved bioactivity. hCT
28  2018 Intra-articular delivery of a nanocomplex comprising salmon calcitonin, hyaluronic acid, and chitosan using an equine model of joint inflammation. CS, HA, IA, LPS, NPs
29  2018 Salmon Calcitonin Attenuates Degenerative Changes in Cartilage and Subchondral Bone in Lumbar Facet Joint in an Experimental Rat Model. FJD, LBP
30  2018 Synergistic and non-synergistic effects of salmon calcitonin and omega - 3 fatty acids on antioxidant, anti-inflammatory, and haematological indices in diabetic rats. DHA, DM, EPA
31  2017 Amylin receptor activation in the ventral tegmental area reduces motivated ingestive behavior. VTA
32  2017 Effects of Salmon Calcitonin and Omega - 3 Fatty Acids on Glucoregulatory Indices, Lipid Profile and Antioxidant Markers in Experimental Knee Osteoarthritis in Wistar Rats. DF, NO, OA
33  2017 Effects of single or combined administration of salmon calcitonin and omega-3 fatty acids vs. diclofenac sodium in sodium monoiodoacetate-induced knee osteoarthritis in male Wistar rats. CAT, DF, IL-6, MDA, OA, SOD, UA
34  2017 Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time. hCT
35  2017 Supramolecular nanoparticles of calcitonin and dipeptide for long-term controlled release. ---
36  2017 The area postrema (AP) and the parabrachial nucleus (PBN) are important sites for salmon calcitonin (sCT) to decrease evoked phasic dopamine release in the nucleus accumbens (NAc). AP, DA, NAc, PBN, VTA
37  2016 A novel strategy for the preparation of porous microspheres and its application in peptide drug loading. PEG
38  2016 Amorphous Calcium Carbonate Based-Microparticles for Peptide Pulmonary Delivery. AAT, ACC, HA
40  2016 Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage. CA, CG, i.c, i.j, PEs, SmPill
41  2016 How Glycosaminoglycans Promote Fibrillation of Salmon Calcitonin. GAGs
42  2016 Monosialoganglioside-GM1 triggers binding of the amyloid-protein salmon calcitonin to a Langmuir membrane model mimicking the occurrence of lipid-rafts. ---
43  2016 Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis. ---
44  2016 Preparation and Evaluation of Enteric-Coated Chitosan Derivative-Based Microparticles Loaded with Salmon Calcitonin as an Oral Delivery System. CH, Ch-TBA, MP, TMC
45  2015 Acylation of salmon calcitonin modulates in vitro intestinal peptide flux through membrane permeability enhancement. ---
46  2015 Chondroitin-based nanoplexes as peptide delivery systems--Investigations into the self-assembly process, solid-state and extended release characteristics. CHON, PROT
47  2015 Design of salmon calcitonin particles for nasal delivery using spray-drying and novel supercritical fluid-assisted spray-drying processes. FTIR, HPLC, PXRD, SASD, SD, SEM
48  2015 Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats. ASA, BMD, OPG, RANKL
49  2015 Formulation, stability and pharmacokinetics of sugar-based salmon calcitonin-loaded nanoporous/nanoparticulate microparticles (NPMPs) for inhalation. DPI, FPF, MMAD, NPMPs
50  2015 Microinjection of calcitonin in midbrain periaqueductal gray attenuates hyperalgesia in a chronic constriction injury rat model. CCI, CT, CTR, MWT, PAG, TWL
51  2015 Organic arsenicals as efficient and highly specific linkers for protein/peptide-polymer conjugation. ---
52  2015 Strategic approaches for enhancement of in vivo transbuccal peptide drug delivery in rabbits using iontophoresis and chemical enhancers. NAC, SDGC
53  2015 The inhibitory effect of salmon calcitonin on intervertebral disc degeneration in an ovariectomized rat model. BMD, MMP, SHAM
54  2015 Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials. JSN, JSW, KL, OA, PBO, WOMAC
55  2014 A hyaluronic acid-salmon calcitonin conjugate for the local treatment of osteoarthritis: chondro-protective effect in a rabbit model of early OA. HA, IA, MMP, OA
56  2014 A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats. DACRA, DIO, ZDF
57  2014 Decline in calcitonin receptor expression in osteocytes with age. CTR, DMP1, IL-6, MEPE, PTH, SHAM, SOST
58  2014 Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs. CSK, IRQ, SLNs
59  2014 Effect of lyophilization on liposomal encapsulation of salmon calcitonin. P-NMR
60  2014 Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin. PEG
61  2014 Formulation and evaluation of novel reverse microemulsions containing salmon calcitonin in hydrofluoroalkane propellants. FPF, NGI, pMDIs, TSI
62  2014 Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles. CMR, CS, HA, MMR, NP
63  2014 Investigation of coco-glucoside as a novel intestinal permeation enhancer in rat models. CG, FD4, HCA
64  2014 Native metastable prefibrillar oligomers are the most neurotoxic species among amyloid aggregates. CD, EF-TEM, SEC
65  2014 Novel application of polioviral capsid: development of a potent and prolonged oral calcitonin using polioviral binding ligand and Tat peptide. CPPs
66  2014 Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats. DIO, DIO-STZ
67  2014 Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias. hCT
68  2014 Prolonged hypocalcemic effect by pulmonary delivery of calcitonin loaded poly(methyl vinyl ether maleic acid) bioadhesive nanoparticles. ---
69  2014 Self-assembled hyaluronate/protamine polyelectrolyte nanoplexes: synthesis, stability, biocompatibility and potential use as peptide carriers. HA, NPs, PROT
70  2014 The role of the area postrema in the anorectic effects of amylin and salmon calcitonin: behavioral and neuronal phenotyping. AP, DBH, TPH, VGLUT2
71  2013 A novel spectrofluorimetric method for the determination of calcitonin in ampules through derivatization with fluorescamine. HPLC
72  2013 A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine. PPS
73  2013 An intra-articular salmon calcitonin-based nanocomplex reduces experimental inflammatory arthritis. HA, IA, MMPs, NPs, OA, RA
74  2013 Conjugation-induced fluorescent labeling of proteins and polymers using dithiomaleimides. DTMs
75  2013 Mucoadhesive intestinal devices for oral delivery of salmon calcitonin. EC
76  2013 NMR investigations of structural and dynamics features of natively unstructured drug peptide - salmon calcitonin: implication to rational design of potent sCT analogs. NMR
77  2013 Oral salmon calcitonin protects against impaired fasting glycemia, glucose intolerance, and obesity induced by high-fat diet and ovariectomy in rats. HFD, HOMA-IR, IR
78  2013 Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids. SA, SLNs, TP
79  2013 PHEA-graft-polymethacrylate supramolecular aggregates for protein oral delivery. SAs
80  2013 Role of aromatic residues in amyloid fibril formation of human calcitonin by solid-state 13C NMR and molecular dynamics simulation. CT, hCT
81  2013 Salmon calcitonin use and associated cancer risk. FDA
82  2013 Transdermal absorption and stability enhancement of salmon calcitonin by Tat peptide. CPPs, SC, Tat
83  2012 Delivery of salmon calcitonin using a microneedle patch. MNs
84  2012 Direct peptide bioconjugation/PEGylation at tyrosine with linear and branched polymeric diazonium salts. mPEGs
85  2012 In vitro and in vivo characterisation of PEG-lipid-based micellar complexes of salmon calcitonin for pulmonary delivery. ---
86  2012 In vivo iontophoretic delivery of salmon calcitonin across microporated skin. ITP, MN
87  2012 Investigations into the fate of inhaled salmon calcitonin at the respiratory epithelial barrier. ---
88  2012 Metal ions as cofactors for aggregation of therapeutic peptide salmon calcitonin. ---
89  2012 Mice over-expressing salmon calcitonin have strongly attenuated osteoarthritic histopathological changes after destabilization of the medial meniscus. DMM, OA, Tg, WT
90  2012 Minimizing acylation of peptides in PLGA microspheres. CMCS, HPLC, hPTH, OCT, PLGA
91  2012 Noncovalent PEGylation: different effects of dansyl-, L-tryptophan-, phenylbutylamino-, benzyl- and cholesteryl-PEGs on the aggregation of salmon calcitonin and lysozyme. HEWL, PEGs, Trp
92  2012 Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats. ZDF
93  2012 Oral salmon calcitonin improves fasting and postprandial glycemic control in lean healthy rats. HOMA-IR, OGTT
94  2012 Polymeric dibromomaleimides as extremely efficient disulfide bridging bioconjugation and pegylation agents. PEG, TCEP
95  2012 Salmon calcitonin-loaded Eudragit and Eudragit-PLGA nanoparticles: invitro and invivo evaluation. NaTDC
96  2012 Stability and structure of protein-lipoamino acid colloidal particles: toward nasal delivery of pharmaceutically active proteins. LP, rhEPO, rhGH
97  2012 Synthesis, characterization and evaluation of bone targeting salmon calcitonin analogs in normal and osteoporotic rats. BMD, BP, ELISA, HA, MALDI-TOF, micro-CT
98  2012 The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier. mPEG-g-AA, PIC
99  2012 Ultraviolet Resonance Raman spectroscopy used to study formulations of salmon calcitonin, a starch-peptide conjugate and TGF-beta3. TCP, TGF-beta3, UVRR
100  2011 A new method to increase selectivity of transglutaminase mediated PEGylation of salmon calcitonin and human growth hormone. Gln, hGH, MTGase, PEG